BNP Paribas restated their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report sent to investors on Friday. BNP Paribas currently has a GBX 1,520 ($19.84) price objective on the stock.

A number of other analysts have also weighed in on the stock. Citigroup Inc. set a GBX 1,800 ($23.50) target price on shares of GlaxoSmithKline plc and gave the stock a buy rating in a report on Thursday, September 29th. JPMorgan Chase & Co. reaffirmed a neutral rating on shares of GlaxoSmithKline plc in a report on Thursday, September 22nd. Liberum Capital reaffirmed a buy rating and set a GBX 1,900 ($24.80) target price on shares of GlaxoSmithKline plc in a report on Tuesday, September 20th. Goldman Sachs Group Inc. reaffirmed a buy rating and set a GBX 1,800 ($23.50) target price on shares of GlaxoSmithKline plc in a report on Tuesday, September 20th. Finally, Beaufort Securities reaffirmed a buy rating on shares of GlaxoSmithKline plc in a report on Friday, September 16th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and eight have given a buy rating to the company’s stock. GlaxoSmithKline plc presently has a consensus rating of Hold and a consensus price target of GBX 1,682.13 ($21.96).

GlaxoSmithKline plc (LON:GSK) opened at 1688.50 on Friday. GlaxoSmithKline plc has a 52 week low of GBX 1,277.25 and a 52 week high of GBX 1,716.50. The company’s market cap is GBX 82.08 billion. The company’s 50-day moving average is GBX 1,644.49 and its 200-day moving average is GBX 1,549.54.

The business also recently announced a dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th will be given a GBX 19 ($0.25) dividend. The ex-dividend date of this dividend is Thursday, August 11th. This represents a dividend yield of 1.12%.

In other news, insider Witty,Sir Andrew P sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of GBX 1,693 ($22.10), for a total value of £169,300 ($220,989.43). Also, insider Slaoui,Moncef bought 28 shares of the company’s stock in a transaction dated Friday, August 12th. The stock was bought at an average cost of GBX 2,208 ($28.82) per share, with a total value of £618.24 ($807.00).